Fingolimod
Back to searchMolecule Structure
Scientific Name
Fingolimod
Description of the Drug
Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat patients with the relapsing-remitting form of multiple sclerosis (MS) and studied to manage lung complications of COVID-19.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08868
http://www.drugbank.ca/drugs/DB08868
Brand Name(s)
Gilenya
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Apotex Inc, Hec Pharm Co Ltd, Sun Pharmaceutical Industries Ltd, Biocon Ltd, Accord Healthcare Inc, Glenmark Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Hetero Labs Ltd Unit V
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sphingosine 1-phosphate receptor | PROTEIN FAMILY | BINDING AGENT | CHEMBL2363041 |
Sphingosine 1-phosphate receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363041 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL7445 | |||
Human Metabolome Database | HMDB0252262 | |||
DrugBank | DB08868 | |||
PubChem: Thomson Pharma | 14800795 | |||
PubChem | 107970 | |||
NMRShiftDB | 70114025 | |||
LINCS | LSM-45416 | |||
Nikkaji | J729.665G | |||
BindingDB | 50158336 | |||
EPA CompTox Dashboard | DTXSID40167363 | |||
DrugCentral | 4167 | |||
Brenda | 213385 | 2251 | 212352 | 38999 |
ChemicalBook | CB92498299 | |||
Guide to Pharmacology | 2407 | |||
rxnorm | FINGOLIMOD | GILENYA | FINGOLIMOD HYDROCHLORIDE | |
ChEBI | 63115 | |||
ZINC | ZINC000001542002 |